HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-completion_date&start=46800",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-completion_date&start=46200",
"results": [
{
"registry_id": "NCT05587712",
"publication_url": "https://clinicaltrials.gov/study/NCT05587712",
"title": "A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care",
"has_exemption": false,
"start_date": "2023-01-19",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057935",
"publication_url": "https://clinicaltrials.gov/study/NCT06057935",
"title": "ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185009",
"publication_url": "https://clinicaltrials.gov/study/NCT07185009",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01499888",
"publication_url": "https://clinicaltrials.gov/study/NCT01499888",
"title": "Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)",
"has_exemption": false,
"start_date": "2011-11-11",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06882785",
"publication_url": "https://clinicaltrials.gov/study/NCT06882785",
"title": "A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06252649",
"publication_url": "https://clinicaltrials.gov/study/NCT06252649",
"title": "Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726148",
"publication_url": "https://clinicaltrials.gov/study/NCT06726148",
"title": "An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116031",
"publication_url": "https://clinicaltrials.gov/study/NCT07116031",
"title": "An Open-label, Phase 1/2, Multicenter Study of Belumosudil in Children Aged 1 to <18 Years Requiring Systemic Treatment for Active Moderate-to-severe Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07789548",
"publication_url": "https://clinicaltrials.gov/study/NCT07789548",
"title": "Comparison Between Low-volume Versus Standard-volume Ultrasound-guided Bilateral Intermediate Cervical Plexus Block for Patients Undergoing Thyroidectomy: A Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793942",
"publication_url": "https://clinicaltrials.gov/study/NCT07793942",
"title": "A Phase 2, Open-label Clinical Study to Evaluate the Safety and Efficacy of MK-2010 as Monotherapy and in Combination",
"has_exemption": false,
"start_date": "2026-10-27",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687603",
"publication_url": "https://clinicaltrials.gov/study/NCT06687603",
"title": "Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213609",
"publication_url": "https://clinicaltrials.gov/study/NCT07213609",
"title": "A Phase 1/2 Open-label, Multicenter Study of Oral GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05351801",
"publication_url": "https://clinicaltrials.gov/study/NCT05351801",
"title": "Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143891",
"publication_url": "https://clinicaltrials.gov/study/NCT06143891",
"title": "A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855277",
"publication_url": "https://clinicaltrials.gov/study/NCT06855277",
"title": "A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288073",
"publication_url": "https://clinicaltrials.gov/study/NCT07288073",
"title": "A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Karam Khaddour, MD, MS",
"sponsor_slug": "karam-khaddour-md-ms",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07816666",
"publication_url": "https://clinicaltrials.gov/study/NCT07816666",
"title": "A Randomised, Open-label, Phase III Study of Torvutatug Samrotecan With or Without Bevacizumab Versus Standard of Care as Second- or Third-Line Maintenance Treatment in Participants With Platinum-sensitive Relapsed Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (TREVI-OC-03)",
"has_exemption": false,
"start_date": "2026-09-24",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01410942",
"publication_url": "https://clinicaltrials.gov/study/NCT01410942",
"title": "Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2012-02-08",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01697371",
"publication_url": "https://clinicaltrials.gov/study/NCT01697371",
"title": "Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases",
"has_exemption": false,
"start_date": "2012-08-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01709292",
"publication_url": "https://clinicaltrials.gov/study/NCT01709292",
"title": "Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer",
"has_exemption": false,
"start_date": "2012-11-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02122562",
"publication_url": "https://clinicaltrials.gov/study/NCT02122562",
"title": "Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup",
"has_exemption": false,
"start_date": "2014-04-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mark Niciu",
"sponsor_slug": "mark-niciu",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02131584",
"publication_url": "https://clinicaltrials.gov/study/NCT02131584",
"title": "Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): A Phase II Study",
"has_exemption": false,
"start_date": "2014-09-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02397083",
"publication_url": "https://clinicaltrials.gov/study/NCT02397083",
"title": "Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer",
"has_exemption": false,
"start_date": "2015-09-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02796937",
"publication_url": "https://clinicaltrials.gov/study/NCT02796937",
"title": "An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Grifols Therapeutics LLC",
"sponsor_slug": "grifols-therapeutics-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05370287",
"publication_url": "https://clinicaltrials.gov/study/NCT05370287",
"title": "Adaptive Optics Retinal Imaging",
"has_exemption": false,
"start_date": "2018-01-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Food and Drug Administration (FDA)",
"sponsor_slug": "food-and-drug-administration-fda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03398135",
"publication_url": "https://clinicaltrials.gov/study/NCT03398135",
"title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03650114",
"publication_url": "https://clinicaltrials.gov/study/NCT03650114",
"title": "An Open-label, Single Arm, Multi-center Extension Study Evaluating Long-term Safety, Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2018-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03543839",
"publication_url": "https://clinicaltrials.gov/study/NCT03543839",
"title": "Pilot Trial of Belimumab in Early Lupus",
"has_exemption": false,
"start_date": "2020-09-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04504604",
"publication_url": "https://clinicaltrials.gov/study/NCT04504604",
"title": "TCF-001 TRACK (Target Rare Cancer Knowledge) Study",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TargetCancer Foundation",
"sponsor_slug": "targetcancer-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375033",
"publication_url": "https://clinicaltrials.gov/study/NCT04375033",
"title": "CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04678154",
"publication_url": "https://clinicaltrials.gov/study/NCT04678154",
"title": "Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 - A Continuation of the Multicenter Randomized Control Trial SEXTANT 1",
"has_exemption": false,
"start_date": "2021-05-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Major Extremity Trauma Research Consortium",
"sponsor_slug": "major-extremity-trauma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535271",
"publication_url": "https://clinicaltrials.gov/study/NCT04535271",
"title": "TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04914507",
"publication_url": "https://clinicaltrials.gov/study/NCT04914507",
"title": "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Spine Foundation",
"sponsor_slug": "pediatric-spine-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04526938",
"publication_url": "https://clinicaltrials.gov/study/NCT04526938",
"title": "Clinical Outcomes, Radiation Dosage, and Quality of Life in Patients Treated With Fenestrated Stent Grafts for Complex Thoracoabdominal and Abdominal Aortic Aneurysms, Thoracoabdominal Aortic Aneurysms Secondary to Aortic Dissections",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05116722",
"publication_url": "https://clinicaltrials.gov/study/NCT05116722",
"title": "Shoulder Pacemaker for the Treatment of Scapular Dyskinesia",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05368987",
"publication_url": "https://clinicaltrials.gov/study/NCT05368987",
"title": "Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans",
"has_exemption": false,
"start_date": "2022-02-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04372615",
"publication_url": "https://clinicaltrials.gov/study/NCT04372615",
"title": "A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05197881",
"publication_url": "https://clinicaltrials.gov/study/NCT05197881",
"title": "Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613413",
"publication_url": "https://clinicaltrials.gov/study/NCT05613413",
"title": "LUNG-IST-127: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients With Metastatic sqNSCLC With Disease Control Following Induction Therapy",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05684965",
"publication_url": "https://clinicaltrials.gov/study/NCT05684965",
"title": "A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX301 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xilio Development, Inc.",
"sponsor_slug": "xilio-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05765812",
"publication_url": "https://clinicaltrials.gov/study/NCT05765812",
"title": "A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05941052",
"publication_url": "https://clinicaltrials.gov/study/NCT05941052",
"title": "Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)- Technical Area (TA) 1: Diagnostics- Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)",
"has_exemption": false,
"start_date": "2023-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05979441",
"publication_url": "https://clinicaltrials.gov/study/NCT05979441",
"title": "A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy",
"has_exemption": false,
"start_date": "2023-09-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05854498",
"publication_url": "https://clinicaltrials.gov/study/NCT05854498",
"title": "Phase II Study of Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2023-10-13",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05934487",
"publication_url": "https://clinicaltrials.gov/study/NCT05934487",
"title": "A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056583",
"publication_url": "https://clinicaltrials.gov/study/NCT06056583",
"title": "Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05231629",
"publication_url": "https://clinicaltrials.gov/study/NCT05231629",
"title": "MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 Trial",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828069",
"publication_url": "https://clinicaltrials.gov/study/NCT05828069",
"title": "Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06295744",
"publication_url": "https://clinicaltrials.gov/study/NCT06295744",
"title": "Patient-Reported Outcomes and Cosmesis Following Five Fraction Whole Breast Irradiation With Simultaneous Integrated Boost",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445062",
"publication_url": "https://clinicaltrials.gov/study/NCT06445062",
"title": "A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05804370",
"publication_url": "https://clinicaltrials.gov/study/NCT05804370",
"title": "A Phase 3 Multicenter Study of Gleolan® (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Suspected Newly Diagnosed or Recurrent Epithelial Ovarian Cancer",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NX Development Corp",
"sponsor_slug": "nx-development-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128356",
"publication_url": "https://clinicaltrials.gov/study/NCT06128356",
"title": "Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06226883",
"publication_url": "https://clinicaltrials.gov/study/NCT06226883",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)",
"has_exemption": false,
"start_date": "2024-07-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)",
"sponsor_slug": "morphic-therapeutic-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540833",
"publication_url": "https://clinicaltrials.gov/study/NCT06540833",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI 1284 in Patients With Psychosis Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-08-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06394570",
"publication_url": "https://clinicaltrials.gov/study/NCT06394570",
"title": "Stereotactic Treatment With neoAdjuvant Radiotherapy and Enfortumab Vedotin: a Phase I/II Study With Safety Lead-In for Localized Bladder Cancer (STAR-EV)",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06361940",
"publication_url": "https://clinicaltrials.gov/study/NCT06361940",
"title": "Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer (MAPPER)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194851",
"publication_url": "https://clinicaltrials.gov/study/NCT06194851",
"title": "A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06888063",
"publication_url": "https://clinicaltrials.gov/study/NCT06888063",
"title": "Preventing Liver Recurrence After Partial Hepatectomy for Intrahepatic Cholangiocarcinoma Using Adjuvant Hepatic Arterial Infusion Pump Chemotherapy - PUMP IV Trial",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Erasmus Medical Center",
"sponsor_slug": "erasmus-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06454188",
"publication_url": "https://clinicaltrials.gov/study/NCT06454188",
"title": "A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis (UP-SPOUT)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CARE ARTHRITIS LTD.",
"sponsor_slug": "care-arthritis-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083480",
"publication_url": "https://clinicaltrials.gov/study/NCT06083480",
"title": "Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463028",
"publication_url": "https://clinicaltrials.gov/study/NCT06463028",
"title": "An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699212",
"publication_url": "https://clinicaltrials.gov/study/NCT06699212",
"title": "A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rakuten Medical, Inc.",
"sponsor_slug": "rakuten-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672510",
"publication_url": "https://clinicaltrials.gov/study/NCT06672510",
"title": "Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akura Medical",
"sponsor_slug": "akura-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046106",
"publication_url": "https://clinicaltrials.gov/study/NCT05046106",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleac Pte Ltd.",
"sponsor_slug": "moleac-pte-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931561",
"publication_url": "https://clinicaltrials.gov/study/NCT06931561",
"title": "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649058",
"publication_url": "https://clinicaltrials.gov/study/NCT06649058",
"title": "EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236607",
"publication_url": "https://clinicaltrials.gov/study/NCT06236607",
"title": "Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Medical Center",
"sponsor_slug": "boston-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406777",
"publication_url": "https://clinicaltrials.gov/study/NCT06406777",
"title": "Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Fain",
"sponsor_slug": "sean-fain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/study/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892548",
"publication_url": "https://clinicaltrials.gov/study/NCT06892548",
"title": "A Phase Ib/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Recommended Combination Dose of BNT324 With BNT327 in Participants With Advanced Lung Cancer",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06901531",
"publication_url": "https://clinicaltrials.gov/study/NCT06901531",
"title": "A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003984",
"publication_url": "https://clinicaltrials.gov/study/NCT07003984",
"title": "A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children 1 to <12 Years of Age",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649695",
"publication_url": "https://clinicaltrials.gov/study/NCT06649695",
"title": "A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047716",
"publication_url": "https://clinicaltrials.gov/study/NCT07047716",
"title": "A Phase 3, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Once-Yearly Intramuscular Lenacapavir for HIV Pre-exposure Prophylaxis (PrEP) in People With an Indication for PrEP",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179601",
"publication_url": "https://clinicaltrials.gov/study/NCT07179601",
"title": "Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010887",
"publication_url": "https://clinicaltrials.gov/study/NCT07010887",
"title": "Defining the Role of Repetitive Head Impact Time Intervals in Mitigating Subconcussive Neural Injury",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799494",
"publication_url": "https://clinicaltrials.gov/study/NCT06799494",
"title": "Comparing the Antibody and B Cell Responses Induced by 1- or 2-dose 9-valent HPV (9vHPV) Vaccination in Healthy Adults",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128589",
"publication_url": "https://clinicaltrials.gov/study/NCT07128589",
"title": "Clinical Evaluation of 3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York University",
"sponsor_slug": "new-york-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070012",
"publication_url": "https://clinicaltrials.gov/study/NCT06070012",
"title": "Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833320",
"publication_url": "https://clinicaltrials.gov/study/NCT06833320",
"title": "A Double-blind, Prospective, Randomized Trial of Propranolol for the Treatment of Postoperative Chylothorax After Open Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "June Wu",
"sponsor_slug": "june-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174908",
"publication_url": "https://clinicaltrials.gov/study/NCT07174908",
"title": "A Phase 3 Multicenter, Randomized, Controlled, and Open-Label Study of IN10018 in Combination With D-1553 Versus Standard Therapy for the Treatment of First Line Locally-advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "InxMed (Shanghai) Co., Ltd.",
"sponsor_slug": "inxmed-shanghai-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095361",
"publication_url": "https://clinicaltrials.gov/study/NCT07095361",
"title": "Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema (ONLY ONCE)",
"has_exemption": false,
"start_date": "2025-09-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197827",
"publication_url": "https://clinicaltrials.gov/study/NCT07197827",
"title": "A Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL242 Monotherapy and Combinations in Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MediLink Therapeutics (Suzhou) Co., Ltd.",
"sponsor_slug": "medilink-therapeutics-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956209",
"publication_url": "https://clinicaltrials.gov/study/NCT06956209",
"title": "A First-in-Human, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of an Implantable Device for Direct Bladder Wall Stimulation in Participants With Lower Urinary Tract Symptoms of Underactive Bladder",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Iota Biosciences, Inc",
"sponsor_slug": "iota-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157865",
"publication_url": "https://clinicaltrials.gov/study/NCT07157865",
"title": "A Comparison of Prism Adaptation Training (PAT) Paired With Transcutaneous Electrical Stimulation (TENS) vs PAT Alone on Outcomes in Post-Stroke Patients Experiencing Unilateral Spatial Neglect (USN)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kettering Health Network",
"sponsor_slug": "kettering-health-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201298",
"publication_url": "https://clinicaltrials.gov/study/NCT07201298",
"title": "A Prospective Contralateral Comparison of Ray-Tracing Guided LASIK (WaveLight® Plus LASIK) vs. Small Incision Lenticule Extraction (SMILE® Pro) Using VisuMax® 800, or Wavefront Optimized LASIK or Topography Guided LASIK (Contoura LASIK): A Three-Phase Visual Outcomes Study.",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoopes Vision",
"sponsor_slug": "hoopes-vision",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745908",
"publication_url": "https://clinicaltrials.gov/study/NCT06745908",
"title": "Randomized, Two-Cohort, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070219",
"publication_url": "https://clinicaltrials.gov/study/NCT07070219",
"title": "A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Imviva Bio",
"sponsor_slug": "imviva-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07407920",
"publication_url": "https://clinicaltrials.gov/study/NCT07407920",
"title": "Optimization of Adjuvant Systemic Therapy in Patients With Early HER2-Positive (HER2+) Breast Cancer or Triple Negative Breast Cancer (TNBC) That Achieved a Pathological Complete Response (pCR) After Neoadjuvant Systemic Therapy and Do Not Have Molecular Residual Disease (MRD-Negative): A Phase II Clinical Trial (The MolecularPCR Trial)",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112183",
"publication_url": "https://clinicaltrials.gov/study/NCT07112183",
"title": "An Open Label Study to Assess Efficacy of Oral Treprostinil Titrated to 3.0mg Three Times Daily or Highest Tolerable Dose in 30 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Standard Vasodilatory Therapy",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06983470",
"publication_url": "https://clinicaltrials.gov/study/NCT06983470",
"title": "Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation",
"has_exemption": false,
"start_date": "2025-10-16",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224542",
"publication_url": "https://clinicaltrials.gov/study/NCT07224542",
"title": "Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care",
"has_exemption": false,
"start_date": "2025-10-19",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256392",
"publication_url": "https://clinicaltrials.gov/study/NCT07256392",
"title": "A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Who Have Completed CDX0159-12 or CDX0159-13",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celldex Therapeutics",
"sponsor_slug": "celldex-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220005",
"publication_url": "https://clinicaltrials.gov/study/NCT07220005",
"title": "Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization",
"has_exemption": false,
"start_date": "2025-12-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07132190",
"publication_url": "https://clinicaltrials.gov/study/NCT07132190",
"title": "A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayal A. Aizer, MD",
"sponsor_slug": "ayal-a-aizer-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160205",
"publication_url": "https://clinicaltrials.gov/study/NCT07160205",
"title": "A Phase 2-Phase 3, Double-blinded, Randomized, Dose-repeating, Cross-over Study to Assess the Safety and Efficacy of Allogeneic ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM)",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Restem, LLC.",
"sponsor_slug": "restem-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049055",
"publication_url": "https://clinicaltrials.gov/study/NCT07049055",
"title": "A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Engeneic Pty Limited",
"sponsor_slug": "engeneic-pty-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214311",
"publication_url": "https://clinicaltrials.gov/study/NCT07214311",
"title": "RETAIN: A Phase 2/3 Randomized, Placebo-Controlled Study to Evaluate the Efficacy of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Total Knee Arthroplasty (TKA)",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Peptilogics",
"sponsor_slug": "peptilogics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226791",
"publication_url": "https://clinicaltrials.gov/study/NCT07226791",
"title": "A Phase 2 Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186660",
"publication_url": "https://clinicaltrials.gov/study/NCT07186660",
"title": "Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery",
"has_exemption": false,
"start_date": "2026-02-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904378",
"publication_url": "https://clinicaltrials.gov/study/NCT06904378",
"title": "Phase I/II Clinical Trial of ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma: Reprogramming Tumor-associated Myeloid Cells",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07182227",
"publication_url": "https://clinicaltrials.gov/study/NCT07182227",
"title": "A Phase 1/2 Multicenter, Open Label, Two-part Study (Single Ascending Dose [Part 1], and Dose Expansion [Part 2]) to Evaluate Safety, Tolerability and Efficacy of PS-002, a Gene Therapy for the Treatment of Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Purespring Therapeutics Limited",
"sponsor_slug": "purespring-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282847",
"publication_url": "https://clinicaltrials.gov/study/NCT07282847",
"title": "A Single-Arm, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of AB-1009 in Adult Participants With Late-Onset Pompe Disease (LOPD)",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AskBio Inc",
"sponsor_slug": "askbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144150",
"publication_url": "https://clinicaltrials.gov/study/NCT07144150",
"title": "Advance Evero™ 18 Everolimus-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Versus Paclitaxel-coated Ballons in Patients With Femoropopliteal Disease (EVERO Trial)",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Research Incorporated",
"sponsor_slug": "cook-research-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094711",
"publication_url": "https://clinicaltrials.gov/study/NCT07094711",
"title": "Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG in Patients With Mycobacterium Avium Complex Lung Disease (BOOST)",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07539311",
"publication_url": "https://clinicaltrials.gov/study/NCT07539311",
"title": "A Phase 2, Open-label, Multicohort, Study of Rinatabart Sesutecan (Rina S) in Participants With Advanced Gastrointestinal (GI) Cancers",
"has_exemption": false,
"start_date": "2026-05-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278479",
"publication_url": "https://clinicaltrials.gov/study/NCT07278479",
"title": "A Phase 1/2a Study to Assess Safety, Tolerability, and Efficacy of [212Pb]Pb-DOTAM-MAM279 in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Molecular Partners AG",
"sponsor_slug": "molecular-partners-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431099",
"publication_url": "https://clinicaltrials.gov/study/NCT07431099",
"title": "Skin Color Matching in Head and Neck Reconstructive Surgery Using RECELL® Autologous Skin Cell Suspension: A Prospective, Pilot Study",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429266",
"publication_url": "https://clinicaltrials.gov/study/NCT07429266",
"title": "A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of Sapablursen in Polycythemia Vera",
"has_exemption": false,
"start_date": "2026-05-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07550088",
"publication_url": "https://clinicaltrials.gov/study/NCT07550088",
"title": "A Single-Arm, Phase II Study Evaluating Combination Balstilimab Plus Botensilimab With AgenT-797 in Previously Treated Patients With pMMR Metastatic CRC With Liver Metastases",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Darren Sigal, MD",
"sponsor_slug": "darren-sigal-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07642050",
"publication_url": "https://clinicaltrials.gov/study/NCT07642050",
"title": "A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of BHV-1400 in the Treatment of IgA Nephropathy",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145866",
"publication_url": "https://clinicaltrials.gov/study/NCT07145866",
"title": "Evaluation of Varenicline and Accelerated TMS for Reduction of Nicotine Use",
"has_exemption": false,
"start_date": "2026-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439172",
"publication_url": "https://clinicaltrials.gov/study/NCT07439172",
"title": "A Multi-Centered Evaluation of Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma (HGG): An Approach to Drug Screening That Requires Confirmation",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cooper Health System",
"sponsor_slug": "the-cooper-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07654361",
"publication_url": "https://clinicaltrials.gov/study/NCT07654361",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Pivotal Phase 3 Study to Evaluate the Long-Term Efficacy and Safety of Multiple Maintenance Doses of Once Daily Oral Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and a Weight-Related Comorbidity",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics",
"sponsor_slug": "gasherbrum-bio-inc-a-wholly-owned-subsidiary-of-structure-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07750873",
"publication_url": "https://clinicaltrials.gov/study/NCT07750873",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of CRD-4730 in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cardurion Pharmaceuticals, Inc.",
"sponsor_slug": "cardurion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07654374",
"publication_url": "https://clinicaltrials.gov/study/NCT07654374",
"title": "A Long-Term Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Multiple Maintenance Doses of Oral Once Daily Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)",
"has_exemption": false,
"start_date": "2026-07-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics",
"sponsor_slug": "gasherbrum-bio-inc-a-wholly-owned-subsidiary-of-structure-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979076",
"publication_url": "https://clinicaltrials.gov/study/NCT06979076",
"title": "A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MingSight Pharmaceuticals, Inc.",
"sponsor_slug": "mingsight-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183644",
"publication_url": "https://clinicaltrials.gov/study/NCT07183644",
"title": "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07612267",
"publication_url": "https://clinicaltrials.gov/study/NCT07612267",
"title": "A Study to Evaluate Mirikizumab Concentrations in Breast Milk Following Administration of Mirikizumab by Subcutaneous Injection in Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication",
"has_exemption": false,
"start_date": "2026-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07667387",
"publication_url": "https://clinicaltrials.gov/study/NCT07667387",
"title": "Master Protocol for a Phase I/II Open-label Safety and Efficacy Study of LNP.UCD.ABE, a Lipid Nanoparticle-delivered Base Editing Therapy, in Patients With Urea Cycle Disorders Due to Variants Amenable to Corrective Editing by LNP.UCD.ABE",
"has_exemption": false,
"start_date": "2026-08-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rebecca Ahrens-Nicklas",
"sponsor_slug": "rebecca-ahrens-nicklas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680140",
"publication_url": "https://clinicaltrials.gov/study/NCT07680140",
"title": "Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2026-08-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07769502",
"publication_url": "https://clinicaltrials.gov/study/NCT07769502",
"title": "A Phase 2, Open-Label, Master Protocol Study to Evaluate Safety and Efficacy of Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Pancreatobiliary Cancers (AndroMETa-118)",
"has_exemption": false,
"start_date": "2026-08-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07808346",
"publication_url": "https://clinicaltrials.gov/study/NCT07808346",
"title": "Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease",
"has_exemption": false,
"start_date": "2026-08-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07491367",
"publication_url": "https://clinicaltrials.gov/study/NCT07491367",
"title": "Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743983",
"publication_url": "https://clinicaltrials.gov/study/NCT07743983",
"title": "A Randomized, Open-Label, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety, and Diabetes Remission of BGM0504 Injection Compared With Semaglutide Injection in Early-Stage Chinese Type 2 Diabetes Mellitus Patients With Obesity and Inadequate Glycemic and Weight Control Despite Diet and Exercise Intervention（BRIGHT-1）",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BrightGene Bio-Medical Technology Co., Ltd.",
"sponsor_slug": "brightgene-bio-medical-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07855770",
"publication_url": "https://clinicaltrials.gov/study/NCT07855770",
"title": "A Prospective, Randomized Study on the Use of Preoperative Gas in Eyes With Macula-off Rhegmatogenous Retinal Detachment (RRD)",
"has_exemption": false,
"start_date": "2026-09-21",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wills Eye",
"sponsor_slug": "wills-eye",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956014",
"publication_url": "https://clinicaltrials.gov/study/NCT06956014",
"title": "Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy",
"has_exemption": false,
"start_date": "2026-09-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertanical GmbH",
"sponsor_slug": "vertanical-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07879326",
"publication_url": "https://clinicaltrials.gov/study/NCT07879326",
"title": "mHealth OAE: Towards Implementation of Universal Newborn Hearing Screening in Kenya - R33 Phase (mTUNE-R33)",
"has_exemption": false,
"start_date": "2026-09-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526377",
"publication_url": "https://clinicaltrials.gov/study/NCT06526377",
"title": "Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Efficacy and Safety of Vilamakitug in Participants With Active Axial Spondyloarthritis",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "XBiotech, Inc.",
"sponsor_slug": "xbiotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712433",
"publication_url": "https://clinicaltrials.gov/study/NCT06712433",
"title": "Bacterial Decolonization Plus Intraoperative Indocyanine Green Angiography for Soft Tissue Sarcomas of the Lower Extremity Receiving Preoperative Radiotherapy (CONCERTO)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Olson",
"sponsor_slug": "adam-olson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07452146",
"publication_url": "https://clinicaltrials.gov/study/NCT07452146",
"title": "Understanding the Role of Inflammation in Alcohol Use Disorder: An Inflammatory Challenge Using Lipopolysaccharide",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07537855",
"publication_url": "https://clinicaltrials.gov/study/NCT07537855",
"title": "Clinical Efficacy of Intracavernosal Xeomin as an Adjunctive Therapy to on Demand Tadalafil 20 mg for the Treatment of Mild to Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07540832",
"publication_url": "https://clinicaltrials.gov/study/NCT07540832",
"title": "An Open-Label Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced Hepatocellular Carcinoma as Second Line Therapy",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhejiang Haichang Biotech Co., Ltd.",
"sponsor_slug": "zhejiang-haichang-biotech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07565857",
"publication_url": "https://clinicaltrials.gov/study/NCT07565857",
"title": "SIGNAL GEC-101: Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07581405",
"publication_url": "https://clinicaltrials.gov/study/NCT07581405",
"title": "GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596212",
"publication_url": "https://clinicaltrials.gov/study/NCT07596212",
"title": "BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623460",
"publication_url": "https://clinicaltrials.gov/study/NCT07623460",
"title": "ZENITH: Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stuthi Perimbeti",
"sponsor_slug": "stuthi-perimbeti",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680088",
"publication_url": "https://clinicaltrials.gov/study/NCT07680088",
"title": "A Multicenter Single-arm Phase 2 Study of Pembrolizumab and Lenvatinib in Previously Treated Inoperable or Advanced Anal Squamous Cell Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07684170",
"publication_url": "https://clinicaltrials.gov/study/NCT07684170",
"title": "A Phase 2, Open-Label Study of CTX-471 in Patients With NCAM Positive Tumors",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Compass Therapeutics",
"sponsor_slug": "compass-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07765212",
"publication_url": "https://clinicaltrials.gov/study/NCT07765212",
"title": "Open-Label, Single-Center, Single-Arm Phase 2 Futility Trial Evaluating the Use of Oral Indapamide for Reducing Pprogression of Disability in People With Primary and Secondary Progressive Multiple Sclerosis (MS)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva M.M. Strijbis",
"sponsor_slug": "eva-mm-strijbis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07764783",
"publication_url": "https://clinicaltrials.gov/study/NCT07764783",
"title": "Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Association of Migraine Disorders",
"sponsor_slug": "association-of-migraine-disorders",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07799441",
"publication_url": "https://clinicaltrials.gov/study/NCT07799441",
"title": "Neurovascular Effects of Empagliflozin in Mid-Life and Older Adults With Prehypertension",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kanokwan Bunsawat",
"sponsor_slug": "kanokwan-bunsawat",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07794670",
"publication_url": "https://clinicaltrials.gov/study/NCT07794670",
"title": "A Phase 2b, Randomized, Double Blind, Placebo Controlled, Parallel Group Trial to Assess the Efficacy and Safety of Obicetrapib in Participants With Preclinical Alzheimer's Disease (SPINOZA Trial)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NewAmsterdam Pharma",
"sponsor_slug": "newamsterdam-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07799220",
"publication_url": "https://clinicaltrials.gov/study/NCT07799220",
"title": "A Phase II Study of MRD-guided Zanubrutinib, Obinutuzumab, and Sonrotoclax (BOSon) for Previously Untreated Transplant-ineligible Patients With Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07835295",
"publication_url": "https://clinicaltrials.gov/study/NCT07835295",
"title": "REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07868913",
"publication_url": "https://clinicaltrials.gov/study/NCT07868913",
"title": "ASPIRED: Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department - A Randomized Clinical Trial.",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743697",
"publication_url": "https://clinicaltrials.gov/study/NCT07743697",
"title": "SEAL-TAVI - Suture vs combinEd Closure strAtegies in Large-bore Access After TAVI",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Basel, Switzerland",
"sponsor_slug": "university-hospital-basel-switzerland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07754695",
"publication_url": "https://clinicaltrials.gov/study/NCT07754695",
"title": "Prospective Measurement of Normative Esophageal Distensibility Using EndoFLIP in Asymptomatic Children",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07520955",
"publication_url": "https://clinicaltrials.gov/study/NCT07520955",
"title": "Using Temporal Interference to Non-Invasively Enhance Sleep Homeostasis in Patients With Epilepsy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07706179",
"publication_url": "https://clinicaltrials.gov/study/NCT07706179",
"title": "Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer: A Biomarker-Driven Pilot Clinical Trial",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07756346",
"publication_url": "https://clinicaltrials.gov/study/NCT07756346",
"title": "Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06746753",
"publication_url": "https://clinicaltrials.gov/study/NCT06746753",
"title": "Mechanistic Assessment of Norepinephrine TheRapy vs. Angiotensin-II in Septic Shock (MANTRA) Grant Submission- Dysfunctional Renin-Angiotensin System in Septic Shock",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223528",
"publication_url": "https://clinicaltrials.gov/study/NCT07223528",
"title": "A Phase 2a Single Arm Open Label Safety and Efficacy Study of Telaglenastat Plus Standard of Care in Adults With Functional Class Ii-iii Precapillary Pulmonary Hypertension Across Wsph Groups 1-3",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Chan, Stephen, MD, PhD",
"sponsor_slug": "chan-stephen-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07696182",
"publication_url": "https://clinicaltrials.gov/study/NCT07696182",
"title": "VOYAGER CE Clinical Trial : Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07838194",
"publication_url": "https://clinicaltrials.gov/study/NCT07838194",
"title": "A Multicenter, Open-Label, Single-Arm, Phase III Clinical Trial to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of NXT007 Prophylaxis in Pediatric Patients With Hemophilia A",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07884240",
"publication_url": "https://clinicaltrials.gov/study/NCT07884240",
"title": "Weekly Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Young African Women",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995521",
"publication_url": "https://clinicaltrials.gov/study/NCT06995521",
"title": "Use of Vorinostat as GVHD Prophylaxis in Children, Adolescents, and Young Adults With Non-Malignant Disorders Undergoing Allogeneic Blood and Marrow Transplantation",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sung Won Choi",
"sponsor_slug": "sung-won-choi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179952",
"publication_url": "https://clinicaltrials.gov/study/NCT07179952",
"title": "A Study to Evaluate Efficacy and Safety of Slow Release DHEA",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864313",
"publication_url": "https://clinicaltrials.gov/study/NCT05864313",
"title": "Gaze and Gait Training With Neuromodulation",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06792500",
"publication_url": "https://clinicaltrials.gov/study/NCT06792500",
"title": "Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04339777",
"publication_url": "https://clinicaltrials.gov/study/NCT04339777",
"title": "A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity",
"has_exemption": false,
"start_date": "2020-09-22",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04301843",
"publication_url": "https://clinicaltrials.gov/study/NCT04301843",
"title": "Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2020-09-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04269902",
"publication_url": "https://clinicaltrials.gov/study/NCT04269902",
"title": "Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05058651",
"publication_url": "https://clinicaltrials.gov/study/NCT05058651",
"title": "Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)",
"has_exemption": false,
"start_date": "2022-06-28",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05518188",
"publication_url": "https://clinicaltrials.gov/study/NCT05518188",
"title": "A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06349434",
"publication_url": "https://clinicaltrials.gov/study/NCT06349434",
"title": "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06284564",
"publication_url": "https://clinicaltrials.gov/study/NCT06284564",
"title": "A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06516978",
"publication_url": "https://clinicaltrials.gov/study/NCT06516978",
"title": "A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined With Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/PD1 (Pola-RCHP-X) Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital with Nanjing Medical University",
"sponsor_slug": "the-first-affiliated-hospital-with-nanjing-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635629",
"publication_url": "https://clinicaltrials.gov/study/NCT06635629",
"title": "Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644183",
"publication_url": "https://clinicaltrials.gov/study/NCT06644183",
"title": "A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer R. Brown, MD, PhD",
"sponsor_slug": "jennifer-r-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06480760",
"publication_url": "https://clinicaltrials.gov/study/NCT06480760",
"title": "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients; Randomized Intervention Trial (CIPHER)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shahid Baba",
"sponsor_slug": "shahid-baba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05639972",
"publication_url": "https://clinicaltrials.gov/study/NCT05639972",
"title": "A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christian Hinrichs",
"sponsor_slug": "christian-hinrichs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209449",
"publication_url": "https://clinicaltrials.gov/study/NCT07209449",
"title": "A Phase II, Randomization, Unblinded Study of ELacestrant in Combination With Abemaciclib or Elacestrant Alone In p53 Wild Type, Estrogen Receptor-positive Advanced or recurrenT Endometrial Cancer (ELITE)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986174",
"publication_url": "https://clinicaltrials.gov/study/NCT06986174",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shayna Sarosiek, MD",
"sponsor_slug": "shayna-sarosiek-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408246",
"publication_url": "https://clinicaltrials.gov/study/NCT06408246",
"title": "Accelerating Cognition-guided Signatures to Enhance Translation in Depression Aim 3: Clinical Cognitive Trial",
"has_exemption": false,
"start_date": "2026-03-03",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06962657",
"publication_url": "https://clinicaltrials.gov/study/NCT06962657",
"title": "Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434843",
"publication_url": "https://clinicaltrials.gov/study/NCT07434843",
"title": "PEMIGIST: Phase 2 Study of Pemigatinib (INCB054828) in the Treatment of Patients With Advanced SDH-deficient Gastrointestinal Stromal Tumor (GIST)",
"has_exemption": false,
"start_date": "2026-05-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013591",
"publication_url": "https://clinicaltrials.gov/study/NCT07013591",
"title": "Randomized Clinical Trial of Beta Nicotinamide Mononucleotide in Patients Undergoing Cardiac Surgery",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07139106",
"publication_url": "https://clinicaltrials.gov/study/NCT07139106",
"title": "Dynorphin/Kappa Opioid Receptor Signaling Role in Ketamine's Anti-suicidal Ideation Effect",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07820969",
"publication_url": "https://clinicaltrials.gov/study/NCT07820969",
"title": "Post-operative Analgesia of Nail Unit Procedures: A Prospective Pilot Study Comparing Suzetrigine vs. Oxycodone+Acetaminophen vs. Acetaminophen/Ibuprofen",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07835932",
"publication_url": "https://clinicaltrials.gov/study/NCT07835932",
"title": "Randomised Controlled Trial of Fluorescent Urography Using Intravenous Methylene Blue Compared to White Light Alone in Left-sided Colorectal Surgery",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Chinese University of Hong Kong",
"sponsor_slug": "chinese-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07711483",
"publication_url": "https://clinicaltrials.gov/study/NCT07711483",
"title": "Phase 2 Study of Glofitamab and Gemcitabine and Oxaliplatin (Glofit-GemOx) Bridging to Lisocabtagene Maraleucel in Relapsed/Refractory Aggressive B-cell Lymphomas",
"has_exemption": false,
"start_date": "2026-10-14",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07719608",
"publication_url": "https://clinicaltrials.gov/study/NCT07719608",
"title": "Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Salvia BioElectronics",
"sponsor_slug": "salvia-bioelectronics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07769424",
"publication_url": "https://clinicaltrials.gov/study/NCT07769424",
"title": "Impact of Physiologic Pacemaker Programming on Cognitive Function and Health Status in Patients With Symptomatic Bradycardia",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07514858",
"publication_url": "https://clinicaltrials.gov/study/NCT07514858",
"title": "Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Trial of Lu AF28996 in Adults With Parkinson's Disease Experiencing Motor Fluctuations",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2028-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202274",
"publication_url": "https://clinicaltrials.gov/study/NCT06202274",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003387",
"publication_url": "https://clinicaltrials.gov/study/NCT06003387",
"title": "Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205068",
"publication_url": "https://clinicaltrials.gov/study/NCT07205068",
"title": "Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure",
"has_exemption": false,
"start_date": "2025-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Tennessee Graduate School of Medicine",
"sponsor_slug": "university-of-tennessee-graduate-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05835310",
"publication_url": "https://clinicaltrials.gov/study/NCT05835310",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288034",
"publication_url": "https://clinicaltrials.gov/study/NCT07288034",
"title": "Immunotherapy Biomarker Collection for Metastatic NSCLC to Inform Adaptive Personalized Models Targeting Resistance (IMMUNO-BIOMAP)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-10-08",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05744921",
"publication_url": "https://clinicaltrials.gov/study/NCT05744921",
"title": "An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria",
"has_exemption": false,
"start_date": "2023-03-07",
"completion_date": "2028-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07668414",
"publication_url": "https://clinicaltrials.gov/study/NCT07668414",
"title": "Efficacy and Safety of Zenagamtide s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Obesity (AMAZE 7)",
"has_exemption": false,
"start_date": "2026-09-22",
"completion_date": "2028-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00801489",
"publication_url": "https://clinicaltrials.gov/study/NCT00801489",
"title": "A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia",
"has_exemption": false,
"start_date": "2007-04-04",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03821792",
"publication_url": "https://clinicaltrials.gov/study/NCT03821792",
"title": "A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)",
"has_exemption": false,
"start_date": "2019-07-22",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109219",
"publication_url": "https://clinicaltrials.gov/study/NCT07109219",
"title": "A Modular Phase I/II, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AZD4512 Monotherapy or in Combination With Anticancer Agent(s) in Participants With Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07735637",
"publication_url": "https://clinicaltrials.gov/study/NCT07735637",
"title": "A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment With AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, Versus Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (TE NDMM) (DURGA-6)",
"has_exemption": false,
"start_date": "2026-08-25",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01878617",
"publication_url": "https://clinicaltrials.gov/study/NCT01878617",
"title": "A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2013-06-23",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06492291",
"publication_url": "https://clinicaltrials.gov/study/NCT06492291",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223047",
"publication_url": "https://clinicaltrials.gov/study/NCT07223047",
"title": "A Phase 1/2a, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 As Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07271186",
"publication_url": "https://clinicaltrials.gov/study/NCT07271186",
"title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of ALN-ANG3 in Participants With Diabetic Kidney Disease",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07571746",
"publication_url": "https://clinicaltrials.gov/study/NCT07571746",
"title": "A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Surovatamig in Adults With Antibody-mediated Kidney Disease",
"has_exemption": false,
"start_date": "2026-03-28",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03609216",
"publication_url": "https://clinicaltrials.gov/study/NCT03609216",
"title": "A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations",
"has_exemption": false,
"start_date": "2018-12-10",
"completion_date": "2028-10-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072781",
"publication_url": "https://clinicaltrials.gov/study/NCT06072781",
"title": "A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)",
"has_exemption": false,
"start_date": "2024-03-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815003",
"publication_url": "https://clinicaltrials.gov/study/NCT06815003",
"title": "Phase-2 Study of Vedolizumab Plus Post-Transplant Cyclophosphamide and Short Course Tacrolimus for Graft-versus-Host Disease Prevention After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796998",
"publication_url": "https://clinicaltrials.gov/study/NCT06796998",
"title": "Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06476704",
"publication_url": "https://clinicaltrials.gov/study/NCT06476704",
"title": "Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Centre Paul Strauss",
"sponsor_slug": "centre-paul-strauss",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04067336",
"publication_url": "https://clinicaltrials.gov/study/NCT04067336",
"title": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2019-09-12",
"completion_date": "2028-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843485",
"publication_url": "https://clinicaltrials.gov/study/NCT07843485",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly Petrelintide vs. Placebo in Participants With Overweight or Obesity and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07729462",
"publication_url": "https://clinicaltrials.gov/study/NCT07729462",
"title": "AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, RANDOMIZED, 2-ARM STUDY TO INVESTIGATE THE PREVENTION OF CHRONIC MIGRAINE WITH RIMEGEPANT COMPARED WITH PLACEBO IN PARTICIPANTS 18 YEARS OF AGE OR OLDER",
"has_exemption": false,
"start_date": "2026-08-26",
"completion_date": "2028-10-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197944",
"publication_url": "https://clinicaltrials.gov/study/NCT07197944",
"title": "A Phase 3, Double-blind, Randomized, Parallel Group, Placebo-controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice Weekly, Followed by a Long-term, Open-label Safety Evaluation in Patients With Short Bowel Syndrome-intestinal Failure (SBS-IF)",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2028-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07037004",
"publication_url": "https://clinicaltrials.gov/study/NCT07037004",
"title": "Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-07-08",
"completion_date": "2028-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07849387",
"publication_url": "https://clinicaltrials.gov/study/NCT07849387",
"title": "An Evaluation of Hospital-Acquired Pressure Injury Prevention Using ALLEVYN COMPLETE CARE Sacrum Foam Dressing - A Prospective, Single-Arm Trial (Project Name - PACCT)",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Smith & Nephew, Inc.",
"sponsor_slug": "smith-nephew-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109414",
"publication_url": "https://clinicaltrials.gov/study/NCT07109414",
"title": "Randomized Phase 2/3 Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novita Pharmaceuticals, Inc.",
"sponsor_slug": "novita-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07533942",
"publication_url": "https://clinicaltrials.gov/study/NCT07533942",
"title": "A Phase 2 Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP3507 (ONC206) in Adults With Recurrent Grade 2 or 3 Meningioma",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767903",
"publication_url": "https://clinicaltrials.gov/study/NCT07767903",
"title": "A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of a Fixed Dose of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder",
"has_exemption": false,
"start_date": "2026-08-06",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02407028",
"publication_url": "https://clinicaltrials.gov/study/NCT02407028",
"title": "Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial",
"has_exemption": false,
"start_date": "2018-06-25",
"completion_date": "2028-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Gaylan Rockswold",
"sponsor_slug": "gaylan-rockswold",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07704580",
"publication_url": "https://clinicaltrials.gov/study/NCT07704580",
"title": "A Randomized Open Label, Phase 1b/2 Study to Evaluate Intravenous Administration With Long Dosing Interval Regimens of Sarilumab in Adult Participants With Rheumatoid Arthritis",
"has_exemption": false,
"start_date": "2026-07-02",
"completion_date": "2028-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05755386",
"publication_url": "https://clinicaltrials.gov/study/NCT05755386",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789757",
"publication_url": "https://clinicaltrials.gov/study/NCT06789757",
"title": "An Open Label Phase II Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461948",
"publication_url": "https://clinicaltrials.gov/study/NCT07461948",
"title": "Advanced MRI for Visualization and Quantification of the Tumor Immune Microenvironment (TIME) in Glioblastoma",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593391",
"publication_url": "https://clinicaltrials.gov/study/NCT07593391",
"title": "A Phase 3 Open-label Extension Study to Investigate the Long-term Safety and Efficacy of Orally Administered NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2028-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuren Pharmaceuticals Limited",
"sponsor_slug": "neuren-pharmaceuticals-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04675710",
"publication_url": "https://clinicaltrials.gov/study/NCT04675710",
"title": "Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer",
"has_exemption": false,
"start_date": "2021-06-24",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05007873",
"publication_url": "https://clinicaltrials.gov/study/NCT05007873",
"title": "Phase II Study Assessing Safety and Clinical Activity of the Combination of ASTX727 With Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)",
"has_exemption": false,
"start_date": "2021-10-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430801",
"publication_url": "https://clinicaltrials.gov/study/NCT06430801",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678659",
"publication_url": "https://clinicaltrials.gov/study/NCT06678659",
"title": "A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952453",
"publication_url": "https://clinicaltrials.gov/study/NCT05952453",
"title": "A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06385262",
"publication_url": "https://clinicaltrials.gov/study/NCT06385262",
"title": "Safety, Efficacy, and Tumor Immune Microenvironment Changes With Neoadjuvant Chemotherapy and Cemiplimab With or Without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer: TOP 2301",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932003",
"publication_url": "https://clinicaltrials.gov/study/NCT06932003",
"title": "A Phase Ic/II Clinical Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of Multiple Oral Doses of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2025-07-08",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.",
"sponsor_slug": "leadingtac-pharmaceutical-shaoxing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976619",
"publication_url": "https://clinicaltrials.gov/study/NCT06976619",
"title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213817",
"publication_url": "https://clinicaltrials.gov/study/NCT07213817",
"title": "An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumours.",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308834",
"publication_url": "https://clinicaltrials.gov/study/NCT07308834",
"title": "Phase 1/2a Study to Evaluate the Safety and Tolerability Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2026-08-11",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CarthroniX, Inc.",
"sponsor_slug": "carthronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07586774",
"publication_url": "https://clinicaltrials.gov/study/NCT07586774",
"title": "An Open, Single-center, Prospective, Randomized, Two-armed, Interventional, Post-market Clinical Investigation of 3D Printed Complete Dentures and Milled Complete Dentures During a 5-year Follow-up Period",
"has_exemption": false,
"start_date": "2026-09-11",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dentsply Sirona Implants and Consumables",
"sponsor_slug": "dentsply-sirona-implants-and-consumables",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06065670",
"publication_url": "https://clinicaltrials.gov/study/NCT06065670",
"title": "A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00508443",
"publication_url": "https://clinicaltrials.gov/study/NCT00508443",
"title": "Phase I/II Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) for the Treatment of Metastatic Spine Disease",
"has_exemption": false,
"start_date": "2002-10-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT00501826",
"publication_url": "https://clinicaltrials.gov/study/NCT00501826",
"title": "Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma",
"has_exemption": false,
"start_date": "2007-07-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01269853",
"publication_url": "https://clinicaltrials.gov/study/NCT01269853",
"title": "Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Avastin) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma.",
"has_exemption": false,
"start_date": "2010-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02792582",
"publication_url": "https://clinicaltrials.gov/study/NCT02792582",
"title": "A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection",
"has_exemption": false,
"start_date": "2016-06-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03219359",
"publication_url": "https://clinicaltrials.gov/study/NCT03219359",
"title": "Maintenance in Autologous Stem Cell Transplant for Crohn's Disease (MASCT - CD)",
"has_exemption": false,
"start_date": "2018-02-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aaron Etra",
"sponsor_slug": "aaron-etra",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03503331",
"publication_url": "https://clinicaltrials.gov/study/NCT03503331",
"title": "UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy",
"has_exemption": false,
"start_date": "2018-04-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03614949",
"publication_url": "https://clinicaltrials.gov/study/NCT03614949",
"title": "Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833154",
"publication_url": "https://clinicaltrials.gov/study/NCT03833154",
"title": "A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) Osimertinib Following SBRT, a Single Arm Cohort for Patients With Unresected Stage I/II, Lymph Node Negative NSCLC Harboring a Sensitizing EGFR Mutation",
"has_exemption": false,
"start_date": "2019-03-06",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821129",
"publication_url": "https://clinicaltrials.gov/study/NCT03821129",
"title": "GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04133675",
"publication_url": "https://clinicaltrials.gov/study/NCT04133675",
"title": "A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Stress Urinary Incontinence",
"has_exemption": false,
"start_date": "2019-12-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04230109",
"publication_url": "https://clinicaltrials.gov/study/NCT04230109",
"title": "A Phase 2 Study of Response-guided Neoadjuvant Sacituzumab Govitecan (IMMU-132) in Patients With Localized Triple-Negative Breast Cancer (NeoSTAR)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04553523",
"publication_url": "https://clinicaltrials.gov/study/NCT04553523",
"title": "The Hydrus® Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm, Clinical Trial",
"has_exemption": false,
"start_date": "2020-08-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alcon Research",
"sponsor_slug": "alcon-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04613596",
"publication_url": "https://clinicaltrials.gov/study/NCT04613596",
"title": "A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411823",
"publication_url": "https://clinicaltrials.gov/study/NCT04411823",
"title": "Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04746235",
"publication_url": "https://clinicaltrials.gov/study/NCT04746235",
"title": "A Phase 2 Study of Venetoclax in Combination With ASTX727 in Patients With Relapsed/Refractory Acute Myeloid Leukemia, and Newly Diagnosed Elderly Patients With AML Who Are Not Candidates for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2021-02-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259904",
"publication_url": "https://clinicaltrials.gov/study/NCT05259904",
"title": "Study to Improve dEployment Related Asthma by Using L-citrulline Supplementation (SEALS)",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05532943",
"publication_url": "https://clinicaltrials.gov/study/NCT05532943",
"title": "A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ever Supreme Bio Technology Co., Ltd.",
"sponsor_slug": "ever-supreme-bio-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977998",
"publication_url": "https://clinicaltrials.gov/study/NCT05977998",
"title": "A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821959",
"publication_url": "https://clinicaltrials.gov/study/NCT05821959",
"title": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06076304",
"publication_url": "https://clinicaltrials.gov/study/NCT06076304",
"title": "Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Merenstein",
"sponsor_slug": "daniel-merenstein",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951959",
"publication_url": "https://clinicaltrials.gov/study/NCT05951959",
"title": "A Multicentre, Phase II, Open-label Study to Evaluate the Efficacy of Acalabrutinib in Combination With Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma (TrAVeRse)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05886036",
"publication_url": "https://clinicaltrials.gov/study/NCT05886036",
"title": "NORM: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase 2 Trial With Either Rituximab or Mosunetuzumab",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140537",
"publication_url": "https://clinicaltrials.gov/study/NCT06140537",
"title": "Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05916235",
"publication_url": "https://clinicaltrials.gov/study/NCT05916235",
"title": "Photobiomodulation for Management of Temporomandibular Disorder Pain",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572683",
"publication_url": "https://clinicaltrials.gov/study/NCT06572683",
"title": "Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044623",
"publication_url": "https://clinicaltrials.gov/study/NCT06044623",
"title": "Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Örebro County",
"sponsor_slug": "region-orebro-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06590857",
"publication_url": "https://clinicaltrials.gov/study/NCT06590857",
"title": "Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects With Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) (TRACY-1).",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RayzeBio, Inc.",
"sponsor_slug": "rayzebio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06113016",
"publication_url": "https://clinicaltrials.gov/study/NCT06113016",
"title": "A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors",
"has_exemption": false,
"start_date": "2024-07-23",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216301",
"publication_url": "https://clinicaltrials.gov/study/NCT06216301",
"title": "LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovoCure GmbH",
"sponsor_slug": "novocure-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06579352",
"publication_url": "https://clinicaltrials.gov/study/NCT06579352",
"title": "Study of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) In Patients With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MED Institute Inc.",
"sponsor_slug": "med-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06506422",
"publication_url": "https://clinicaltrials.gov/study/NCT06506422",
"title": "SGLT2 Inhibition as a Therapeutic Strategy to Reverse Arterial Stiffening in Aging",
"has_exemption": false,
"start_date": "2024-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06806930",
"publication_url": "https://clinicaltrials.gov/study/NCT06806930",
"title": "Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903131",
"publication_url": "https://clinicaltrials.gov/study/NCT05903131",
"title": "UPLifT-Endo: Uterine Preservation Via Lifestyle Transformation A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Atypical Endometrial Hyperplasia or Grade 1 Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06733935",
"publication_url": "https://clinicaltrials.gov/study/NCT06733935",
"title": "A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Immune-Mediated Diseases",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nkarta, Inc.",
"sponsor_slug": "nkarta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720908",
"publication_url": "https://clinicaltrials.gov/study/NCT07720908",
"title": "Assessing Labor Epidural Catheter Dysfunction for Tubal Ligation in Parturients Using CompuFlo® CathCheck™ System: A Pilot Study",
"has_exemption": false,
"start_date": "2024-12-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06825689",
"publication_url": "https://clinicaltrials.gov/study/NCT06825689",
"title": "Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942572",
"publication_url": "https://clinicaltrials.gov/study/NCT06942572",
"title": "A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Splice Bio",
"sponsor_slug": "splice-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841055",
"publication_url": "https://clinicaltrials.gov/study/NCT06841055",
"title": "A Phase II, Multisite, Open-label Trial of Pumitamig (BNT327) in Combination With Standard-of-care Chemotherapy in First-line and Second-line Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817668",
"publication_url": "https://clinicaltrials.gov/study/NCT06817668",
"title": "Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533865",
"publication_url": "https://clinicaltrials.gov/study/NCT06533865",
"title": "Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults With Functional Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635811",
"publication_url": "https://clinicaltrials.gov/study/NCT06635811",
"title": "Circadian Adaptive Deep Brain Stimulation in Essential Tremor",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680752",
"publication_url": "https://clinicaltrials.gov/study/NCT06680752",
"title": "A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ARCE Therapeutics, Inc.",
"sponsor_slug": "arce-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06693011",
"publication_url": "https://clinicaltrials.gov/study/NCT06693011",
"title": "Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Endovascular, Inc.",
"sponsor_slug": "cerus-endovascular-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328608",
"publication_url": "https://clinicaltrials.gov/study/NCT06328608",
"title": "Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854159",
"publication_url": "https://clinicaltrials.gov/study/NCT06854159",
"title": "A Phase 2 Study of Odronextamab in Relapsed/ Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Before and After Chimeric Antigen Receptor (CAR) T-Cell Therapy",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416149",
"publication_url": "https://clinicaltrials.gov/study/NCT07416149",
"title": "Reducing Post-operative Hypoparathyroidism With Probe-based Near Infrared Autofluorescence (NIRAF)- Assisted Total Thyroidectomy Versus Conventional Total Thyroidectomy, a Randomized-controlled Trial",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224256",
"publication_url": "https://clinicaltrials.gov/study/NCT07224256",
"title": "VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784336",
"publication_url": "https://clinicaltrials.gov/study/NCT06784336",
"title": "Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115004",
"publication_url": "https://clinicaltrials.gov/study/NCT07115004",
"title": "A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045194",
"publication_url": "https://clinicaltrials.gov/study/NCT07045194",
"title": "A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchestra BioMed, Inc",
"sponsor_slug": "orchestra-biomed-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194850",
"publication_url": "https://clinicaltrials.gov/study/NCT07194850",
"title": "A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223021",
"publication_url": "https://clinicaltrials.gov/study/NCT07223021",
"title": "Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CEll Therapy: a Randomized, Multi-center Study of Children and Young Adults With B-cell Acute Lymphoblastic Leukemia (INFLUENCE)",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06878560",
"publication_url": "https://clinicaltrials.gov/study/NCT06878560",
"title": "EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07612774",
"publication_url": "https://clinicaltrials.gov/study/NCT07612774",
"title": "A Multicenter, Randomized Controlled Comparison of Effect of Evolocumab Versus Standard Lipid Lowering Therapy on Plaque Progression in Patients With Acute Coronary Syndrome by Serial PCCT (CAPRA-EVO Trial)",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West China Hospital",
"sponsor_slug": "west-china-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225751",
"publication_url": "https://clinicaltrials.gov/study/NCT07225751",
"title": "A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kuros Biosurgery AG",
"sponsor_slug": "kuros-biosurgery-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07357415",
"publication_url": "https://clinicaltrials.gov/study/NCT07357415",
"title": "A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial",
"has_exemption": false,
"start_date": "2026-01-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389590",
"publication_url": "https://clinicaltrials.gov/study/NCT07389590",
"title": "A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06510309",
"publication_url": "https://clinicaltrials.gov/study/NCT06510309",
"title": "A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gottfried von Keudell, MD PhD",
"sponsor_slug": "gottfried-von-keudell-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07368998",
"publication_url": "https://clinicaltrials.gov/study/NCT07368998",
"title": "A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination With Fulvestrant in Participants With PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291297",
"publication_url": "https://clinicaltrials.gov/study/NCT07291297",
"title": "Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2026-03-04",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062354",
"publication_url": "https://clinicaltrials.gov/study/NCT07062354",
"title": "A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225270",
"publication_url": "https://clinicaltrials.gov/study/NCT07225270",
"title": "A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum-Sensitive Ovarian Cancer (PSOC)",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891885",
"publication_url": "https://clinicaltrials.gov/study/NCT06891885",
"title": "A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602036",
"publication_url": "https://clinicaltrials.gov/study/NCT07602036",
"title": "Type 2 Diabetes and Pregnancy a Single-arm Interventional Study",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Poznan University of Medical Sciences",
"sponsor_slug": "poznan-university-of-medical-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07555938",
"publication_url": "https://clinicaltrials.gov/study/NCT07555938",
"title": "A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Patients With Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318584",
"publication_url": "https://clinicaltrials.gov/study/NCT07318584",
"title": "Cefotetan Therapy for Escherichia Coli Infections: a Prospective Phase II Pilot Study",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07566364",
"publication_url": "https://clinicaltrials.gov/study/NCT07566364",
"title": "A Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive Measurable Residual Disease",
"has_exemption": false,
"start_date": "2026-07-09",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}